0001209191-17-033265.txt : 20170517 0001209191-17-033265.hdr.sgml : 20170517 20170517172154 ACCESSION NUMBER: 0001209191-17-033265 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170515 FILED AS OF DATE: 20170517 DATE AS OF CHANGE: 20170517 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMARIN CORP PLC\UK CENTRAL INDEX KEY: 0000897448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL, STREET 2: SHELBOURNE ROAD, BALLSBRIDGE CITY: DUBLIN STATE: L2 ZIP: 00000 BUSINESS PHONE: 353 1 6699 020 MAIL ADDRESS: STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL, STREET 2: SHELBOURNE ROAD, BALLSBRIDGE CITY: DUBLIN STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC DATE OF NAME CHANGE: 20000201 FORMER COMPANY: FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC DATE OF NAME CHANGE: 19930322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ekman Lars CENTRAL INDEX KEY: 0001376117 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21392 FILM NUMBER: 17852689 MAIL ADDRESS: STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC. STREET 2: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-15 0 0000897448 AMARIN CORP PLC\UK AMRN 0001376117 Ekman Lars C/O AMARIN PHARMA, INC. 1430 ROUTE 206 BEDMINSTER NJ 07921 1 0 0 0 Stock Option (right to buy) 3.06 2017-05-15 4 A 0 25845 0.00 A 2027-05-15 Ordinary Shares 25845 25845 D Restricted Stock Units 0.00 2017-05-15 4 A 0 17974 0.00 A Ordinary Shares 17974 17974 D On May 15, 2017, the Reporting Person was granted an option to purchase 25,845 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of May 15, 2017 or (ii) the Issuer's annual general meeting of shareholders in 2018. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer. On May 15, 2017 the Reporting Person was granted 17,974 RSUs under the Plan. The RSUs vest in equal annual installments over a three year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of May 15, 2017 or (ii) the Issuer's annual general meeting of shareholders in such year. Not applicable. These grants are made in accordance with the Issuer's previously disclosed non-employee director compensation program. In the event of a Change of Control (as defined in the Plan), each of the grants described in this Form 4 vests in full. /s/ Michael W. Kalb, by power of attorney 2017-05-17